Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI. (Record no. 25920115)

MARC details
000 -LEADER
fixed length control field 01411 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517091438.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201704s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1720-8386
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s40618-016-0466-0
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sabbadin, C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170425
245 00 - TITLE STATEMENT
Title Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of endocrinological investigation
Date of publication, distribution, etc. Sep 2016
300 ## - PHYSICAL DESCRIPTION
Extent 1015-21 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Body Mass Index
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Menstrual Cycle
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Metrorrhagia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mineralocorticoid Receptor Antagonists
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polycystic Ovary Syndrome
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Spironolactone
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ultrasonography
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Andrisani, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zermiani, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Donà, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bordin, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ragazzi, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boscaro, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ambrosini, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Armanini, D
773 0# - HOST ITEM ENTRY
Title Journal of endocrinological investigation
Related parts vol. 39
-- no. 9
-- p. 1015-21
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s40618-016-0466-0">https://doi.org/10.1007/s40618-016-0466-0</a>
Public note Available from publisher's website

No items available.